Mucormycosis infection associated with global COVID-19 pandemic - an institutional histopathological study.

Keerthika, R; Narwal, A; Kamboj, M; Devi, A; Anand, R; N, S; Singh, V; Agarwal, V; Gupta, A

Keerthika, R; Narwal, A; Kamboj, M; Devi, A; Anand, R; N, S; Singh, V; Agarwal, V; Gupta, A.

Affiliation

Keerthika R; Department of Oral and Maxillofacial Pathology and Microbiology Pt. Bhagwat Dayal Sharma University of Health Sciences Post Graduate Institute of Dental Sciences (PGIDS) Rohtak, Haryana-124001, India anjalinarwal@yahoo.com.

Med Oral Patol Oral Cir Bucal ; 28(2): e99-e107, 2023 03 01.

Article in En | MEDLINE | ID: mdl-36806020

Subject(s)

COVID-19; Mucormycosis; Humans; Mucormycosis/diagnosis; Mucormycosis/drug therapy; Mucormycosis/epidemiology; Pandemics; COVID-19/epidemiology; Necrosis/complications; Necrosis/epidemiology; Granuloma

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Mucormycosis Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google